These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22392814)

  • 41. In vivo detection of PARACEST agents with relaxation correction.
    Jones CK; Li AX; Suchý M; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2010 May; 63(5):1184-92. PubMed ID: 20432289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Environmentally sensitive paramagnetic and diamagnetic contrast agents for nuclear magnetic resonance imaging and spectroscopy.
    Pacheco-Torres J; Calle D; Lizarbe B; Negri V; Ubide C; Fayos R; Larrubia PL; Ballesteros P; Cerdan S
    Curr Top Med Chem; 2011; 11(1):115-30. PubMed ID: 20809891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening of CEST MR contrast agents.
    Song X; Chan KW; McMahon MT
    Methods Mol Biol; 2011; 771():171-87. PubMed ID: 21874478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CEST-imaging: A new contrast in MR-mammography by means of chemical exchange saturation transfer.
    Schmitt B; Trattnig S; Schlemmer HP
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S144-6. PubMed ID: 23083567
    [No Abstract]   [Full Text] [Related]  

  • 46. CEST phase mapping using a length and offset varied saturation (LOVARS) scheme.
    Song X; Gilad AA; Joel S; Liu G; Bar-Shir A; Liang Y; Gorelik M; Pekar JJ; van Zijl PC; Bulte JW; McMahon MT
    Magn Reson Med; 2012 Oct; 68(4):1074-86. PubMed ID: 22246684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CEST MRI trackable nanoparticle drug delivery systems.
    Han Z; Liu G
    Biomed Mater; 2021 Feb; 16(2):024103. PubMed ID: 33470986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CEST theranostics: label-free MR imaging of anticancer drugs.
    Li Y; Chen H; Xu J; Yadav NN; Chan KW; Luo L; McMahon MT; Vogelstein B; van Zijl PC; Zhou S; Liu G
    Oncotarget; 2016 Feb; 7(6):6369-78. PubMed ID: 26837220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detecting in vivo urokinase plasminogen activator activity with a catalyCEST MRI contrast agent.
    Sinharay S; Howison CM; Baker AF; Pagel MD
    NMR Biomed; 2017 Jul; 30(7):. PubMed ID: 28370884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies.
    Ali MM; Liu G; Shah T; Flask CA; Pagel MD
    Acc Chem Res; 2009 Jul; 42(7):915-24. PubMed ID: 19514717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enabling hyperpolarized (129) Xe MR spectroscopy and imaging of pulmonary gas transfer to the red blood cells in transgenic mice expressing human hemoglobin.
    Freeman MS; Cleveland ZI; Qi Y; Driehuys B
    Magn Reson Med; 2013 Nov; 70(5):1192-9. PubMed ID: 24006177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular imaging of tumors and metastases using chemical exchange saturation transfer (CEST) MRI.
    Rivlin M; Horev J; Tsarfaty I; Navon G
    Sci Rep; 2013 Oct; 3():3045. PubMed ID: 24157711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic imaging of lymphatic vessels and lymph nodes using a bimodal nanoparticulate contrast agent.
    Mounzer R; Shkarin P; Papademetris X; Constable T; Ruddle NH; Fahmy TM
    Lymphat Res Biol; 2007; 5(3):151-8. PubMed ID: 18035933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of in vivo enzyme activity with CatalyCEST MRI.
    Yoo B; Sheth VR; Howison CM; Douglas MJ; Pineda CT; Maine EA; Baker AF; Pagel MD
    Magn Reson Med; 2014 Mar; 71(3):1221-30. PubMed ID: 23640714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency-encoded MRI-CEST agents based on paramagnetic liposomes/RBC aggregates.
    Ferrauto G; Di Gregorio E; Baroni S; Aime S
    Nano Lett; 2014 Dec; 14(12):6857-62. PubMed ID: 25371974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor-specific expression and detection of a CEST reporter gene.
    Minn I; Bar-Shir A; Yarlagadda K; Bulte JW; Fisher PB; Wang H; Gilad AA; Pomper MG
    Magn Reson Med; 2015 Aug; 74(2):544-9. PubMed ID: 25919119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency importance analysis for chemical exchange saturation transfer magnetic resonance imaging using permuted random forest.
    Chen Y; Dang X; Zhao B; Chen Z; Zhao Y; Zhao F; Zheng Z; He X; Peng J; Song X
    NMR Biomed; 2023 Jun; 36(6):e4744. PubMed ID: 35434864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapy.
    He Y; Zhang L; Zhu D; Song C
    Int J Nanomedicine; 2014; 9():4055-66. PubMed ID: 25187709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRI.
    Qiu LH; Zhang JW; Li SP; Xie C; Yao ZW; Feng XY
    J Magn Reson Imaging; 2015 Apr; 41(4):1056-64. PubMed ID: 24677456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI).
    Yu T; Chan KW; Anonuevo A; Song X; Schuster BS; Chattopadhyay S; Xu Q; Oskolkov N; Patel H; Ensign LM; van Zjil PC; McMahon MT; Hanes J
    Nanomedicine; 2015 Feb; 11(2):401-5. PubMed ID: 25461289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.